Larimar Therapeutics Logo (full size)
Larimar Therapeutics Logo icon/symbol
Larimar Therapeutics Logo (full size) on a dark background
Larimar Therapeutics Logo icon/symbol on a dark background
About Larimar Therapeutics
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.
July 6th, 2024
